Moreover, knocking down these two isoenzymes, ALDH1A1 and ALDH1A3, resulted in decreased ALDH activity, leading to decreased therapy resistance and metastatic behavior in breast cancer cells [75]. The gene discussed is ALDH1A1; the disease is breast carcinoma.